Phase I Study of the Combination of Vorinostat and Radiation Therapy for the Treatment of Patients With Brain Metastases.
Phase of Trial: Phase I
Latest Information Update: 01 Dec 2016
At a glance
- Drugs Vorinostat (Primary)
- Indications Brain metastases
- Focus Adverse reactions
- 11 Apr 2016 Status changed from active, no longer recruiting to completed.
- 23 Feb 2015 Planned End Date changed from 1 Mar 2015 to 1 Feb 2016 as reported by ClinicalTrials.gov.
- 16 May 2014 Planned End Date changed from 1 Mar 2014 to 1 Mar 2015 as reported by ClinicalTrials.gov.